The Phenylephrine Controversy

This chapter discusses the FDA's determination regarding the ineffectiveness of oral phenylephrine in over-the-counter cold medications. The speakers highlight research questioning its efficacy, the implications for consumer safety, and the pharmaceutical industry's responsibility in promoting such drugs. They also explore the ramifications of pulling phenylephrine from the market and skepticism surrounding the motivations for its continued availability.